601 reports of this reaction
2.8% of all GRANISETRON reports
#6 most reported adverse reaction
DEATH is the #6 most commonly reported adverse reaction for GRANISETRON, manufactured by Cumberland Pharmaceuticals Inc.. There are 601 FDA adverse event reports linking GRANISETRON to DEATH. This represents approximately 2.8% of all 21,280 adverse event reports for this drug.
Patients taking GRANISETRON who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for GRANISETRON, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for GRANISETRON:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 601 FDA reports for GRANISETRON. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 2.8% of all adverse event reports for GRANISETRON, making it a notable side effect.
If you experience death while taking GRANISETRON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.